Logo image of AGBA

AGBA GROUP HOLDING LTD (AGBA) Stock Fundamental Analysis

USA - NASDAQ:AGBA - VGG012121023 - Common Stock

1.4 USD
+0.18 (+14.75%)
Last: 10/15/2024, 8:13:02 PM
1.39 USD
-0.01 (-0.71%)
After Hours: 10/15/2024, 8:13:02 PM
Fundamental Rating

1

AGBA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 99 industry peers in the Financial Services industry. AGBA has a bad profitability rating. Also its financial health evaluation is rather negative. AGBA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AGBA had negative earnings in the past year.
AGBA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AGBA reported negative net income in multiple years.
AGBA had negative operating cash flow in 4 of the past 5 years.
AGBA Yearly Net Income VS EBIT VS OCF VS FCFAGBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 50M

1.2 Ratios

The Return On Assets of AGBA (-51.50%) is worse than 94.06% of its industry peers.
Industry RankSector Rank
ROA -51.5%
ROE N/A
ROIC N/A
ROA(3y)-13.05%
ROA(5y)-9.58%
ROE(3y)-503.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGBA Yearly ROA, ROE, ROICAGBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800 -1K

1.3 Margins

AGBA has a Gross Margin (37.97%) which is in line with its industry peers.
AGBA's Gross Margin has declined in the last couple of years.
AGBA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.38%
GM growth 5YN/A
AGBA Yearly Profit, Operating, Gross MarginsAGBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 200 400 600 800

More info and screens

0

2. Health

2.1 Basic Checks

AGBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGBA has more shares outstanding
The number of shares outstanding for AGBA has been increased compared to 5 years ago.
AGBA has a worse debt/assets ratio than last year.
AGBA Yearly Shares OutstandingAGBA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 20M 40M 60M
AGBA Yearly Total Debt VS Total AssetsAGBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -0.99, we must say that AGBA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.99, AGBA is doing worse than 74.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.99
ROIC/WACCN/A
WACC8.89%
AGBA Yearly LT Debt VS Equity VS FCFAGBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.59 indicates that AGBA may have some problems paying its short term obligations.
With a Current ratio value of 0.59, AGBA is not doing good in the industry: 64.36% of the companies in the same industry are doing better.
A Quick Ratio of 0.59 indicates that AGBA may have some problems paying its short term obligations.
With a Quick ratio value of 0.59, AGBA is not doing good in the industry: 64.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
AGBA Yearly Current Assets VS Current LiabilitesAGBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.75% over the past year.
The Revenue for AGBA has decreased by -35.61% in the past year. This is quite bad
AGBA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 56.82% yearly.
EPS 1Y (TTM)37.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.59%
Revenue 1Y (TTM)-35.61%
Revenue growth 3Y56.82%
Revenue growth 5YN/A
Sales Q2Q%-71.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AGBA Yearly Revenue VS EstimatesAGBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AGBA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AGBA Price Earnings VS Forward Price EarningsAGBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGBA Per share dataAGBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AGBA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGBA GROUP HOLDING LTD

NASDAQ:AGBA (10/15/2024, 8:13:02 PM)

After market: 1.39 -0.01 (-0.71%)

1.4

+0.18 (+14.75%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-09 2024-08-09/amc
Earnings (Next)N/A N/A
Inst Owners0.04%
Inst Owner Change0%
Ins Owners30.15%
Ins Owner Change0%
Market Cap264.98M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.91
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.2
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.5%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.97%
FCFM N/A
ROA(3y)-13.05%
ROA(5y)-9.58%
ROE(3y)-503.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.38%
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z -0.99
F-Score5
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)96.28%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.1%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.59%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.61%
Revenue growth 3Y56.82%
Revenue growth 5YN/A
Sales Q2Q%-71.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1415.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1414.68%
OCF growth 3YN/A
OCF growth 5YN/A